Pathological Mechanism of Breast Cancer
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 25 January 2025 | Viewed by 223
Special Issue Editor
Special Issue Information
Dear Colleagues,
Breast cancer stands as the most prevalent malignancy diagnosed globally, impacting countless individuals, and the leading cause of cancer-related death among women, making it an issue on a global scale.
Reasonably, gaining a comprehensive understanding of the intricate pathological mechanisms underpinning breast cancer initiation, progression, metastasis, and treatment resistance emerges as paramount.
Recently, there has been a surge in the exploration of innovative therapeutic targets, biomarkers, and diagnostic tools, which encompasses the integration of liquid biopsy, genomics, proteomics, single-cell analysis, and artificial intelligence. These endeavors are driven by the necessity to enhance patient outcomes and customize treatment strategies to individual needs.
This Special Issue aims to spotlight the recent strides in the pathological mechanisms of breast cancer evolution and treatment, addressing the multitude of lingering questions that remain to be addressed.
We encourage authors to submit original research papers, review articles, meta-analyses, and perspectives contributing to the advancement of our global comprehension of the intricate pathological mechanisms driving the evolution and management of this complex pathology.
Dr. Mariia D. Ivanova
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- metastatic breast cancer
- biomarkers
- molecular profiling
- immune landscape
- genomics
- personalized treatment
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
